http://www.oncologyproductguide.com/blog A comprehensive guide to oncology products for medical professionals Fri, 11 Jun 2010 12:00:01 +0000 http://wordpress.org/?v=2.8.2 en hourly 1 http://www.oncologyproductguide.com/blog/2008/11/06/fda-approves-anda-for-akorn-strides-pamidronate-disodium-injection/ http://www.oncologyproductguide.com/blog/2008/11/06/fda-approves-anda-for-akorn-strides-pamidronate-disodium-injection/#comments Thu, 06 Nov 2008 07:06:19 +0000 Jim Marino http://www.oncologyproductguide.com/blog/2008/11/06/fda-approves-anda-for-akorn-strides-pamidronate-disodium-injection/ The U.S. Food and Drug Administration has granted approval for an Abbreviated New Drug Application for Akorn-Strides‘ Pamidronate Disodium Injection, 3 mg/mL and 9 mg/mL in 10 mL vials. The joint venture between Akorn and Strides was formed to develop liquid, dry powder and lyophilized formulations of generic injectable pharmaceuticals for a wide market with focus on painkillers, anti-infectives and CNS medications. Pamidronate Disodium Injection has received the indication for use in the treatment of hypercalcemia related to tumors and Paget’s disease.

]]> http://www.oncologyproductguide.com/blog/2008/11/06/fda-approves-anda-for-akorn-strides-pamidronate-disodium-injection/feed/ 0